Researcher Profile

Researcher Profile

Diane Hershock, MD, PhD

Diane Hershock, MD, PhD

Associate Professor, Department of Medicine
Division of Hematology and Oncology
Scientific Program:Experimental Therapeutics
Disease Teams:
Head and Neck Cancer
Melanoma and Skin Cancer

Research Interests

  • Radiotherapy
  • Blood Platelets
  • Therapeutics
  • Head and Neck Neoplasms
  • Neoplasms
  • Fibrinogen
  • Survival
  • Drug Therapy
  • Organ Preservation
  • Radiation Oncology
  • Chymotrypsin
  • Carcinoma

Clinical Trials

A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrent Disease in Cutaneous Squamous Cell Carcinoma

Recent Publications




Shenouda, G, Zhang, Q, Ang, KK, Machtay, M, Parliament, MB, Hershock, D, Suntharalingam, M, Lin, A, Rotman, M, Nabid, A, Hong, S, Shehata, S, Cmelak, AJ, Sultanem, K & Le, QT 2015, 'Long-term results of radiation therapy oncology group 9903: A randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck' International Journal of Radiation Oncology Biology Physics, vol. 91, no. 5, pp. 907-915.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)